Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen +/- Toll-like Receptor Agonists for Malignant Glioma
NCT01204684Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Oct 2010
- Primary completion
- Aug 2024
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of autologous tumor lysate-pulsed dendritic cells in malignant glioma, sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Oct 2010; status: completed.
02
Drugs
autologous tumor lysate-pulsed dendritic cells
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT01204684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01204684.